Inflammatory Bowel Diseases: From Bench to Bedside : Proceedings of the Falk Symposium No. 96 (Part IV of the Gastroenterology Symposia 1996) Held in Freiburg-im-Breisgau, Germany, October 30-November 1, 1996
Several international symposia on chronic inflammatory bowel disease over the last few years have contributed to our understanding of the pathophysiology and treatment of this condition. Molecular biology and new analytical techniques have continuously improved our knowledge of mucosal immunology and of inflammatory reactions. Progress in this field is very rapid and has implications for diagnosis and treatment, and makes it important to have a scientific exchange between basic research and clinical practice. This volume, the proceedings of Falk Symposium No. 96, held in Freiburg, Germany, October 30- November 1, 1996, documents the transfer of knowledge between clinicians and basic scientists, and clarifies the definitions used in daily practice such as active disease, refractory diseases or remission. The book will open new aspects for future research and clinical work in the field of inflammatory bowel diseases.
86 pages matching associated in this book
Results 1-3 of 86
What people are saying - Write a review
We haven't found any reviews in the usual places.
Nutrition are there new facts? The importance
Smoking and oral contraceptives in inflammatory bowel
39 other sections not shown
acid active Crohn's disease acute adhesion molecules antibody antigens associated azathioprine bacterial budesonide cancer chronic Clin clinical colectomy colitis and Crohn's collagen colonic Crohn's disease cyclosporine cytokines disease activity disease and ulcerative dose drugs dysplasia effect elemental diet endoscopic enemas epithelial cells expression fibroblasts fistulae function Gastroenterol Gastroenterology gastrointestinal genes genetic growth factor human IFN-y ileal ileostomy ileum immune Immunol increased induced inflammation inflammatory bowel disease inhibition integrins interleukin intestinal epithelial cells intestinal inflammation lamina propria lesions lymphocytes macrophages mast cells measles mediators mesalazine metabolism metronidazole mice mucosal NF-kB NFkB normal nutrition oral pathogenesis patients with Crohn's patients with inflammatory patients with ulcerative peptide placebo pouchitis prednisolone proctocolectomy protein recent receptor recurrence relapse remission resection response risk role short bowel short bowel syndrome small bowel small intestine steroid studies sulphasalazine surgery therapeutic therapy tissue TNF-a treatment tumour necrosis ulcerative colitis